by Vandana Singh | May 13, 2026 | General
Moleculin Biotech Inc. (NASDAQ:MBRX) said it remains on track to unblind the first set of data from its pivotal Phase 2B/3 MIRACLE trial evaluating Annamycin in combination with cytarabine for relapsed or refractory acute myeloid leukemia (AML), before June 30, 2026....
by Parshwa Turakhiya | May 13, 2026 | General
Strategy Inc. (NASDAQ:MSTR) jumped from 4,467 Bitcoin (CRYPTO: BTC) purchases in January to 46,872 BTC in April using STRC preferred stock, creating a mid-month buying pattern that K33 Research says fuels recurring Bitcoin rallies. STRC Ex-Dividend Date Drives...
by Henry Khederian | May 13, 2026 | General
Lucid Group Inc (NASDAQ:LCID) shares are climbing Wednesday afternoon. The bounce comes as investors refocus on Lucid’s longer-dated 2027 ramp narrative after recent attention on a revenue miss and EV demand friction. Here’s what investors need to know. Lucid...
by Parshwa Turakhiya | May 13, 2026 | General
Bitcoin (CRYPTO: BTC) is down to $79,000 after the copper-to-gold ratio broke above its 200-day moving average for the first time since September 2020, a signal that has historically preceded major Bitcoin bull runs. The 2020 Signal Returns The copper-to-gold ratio...
by Vandana Singh | May 13, 2026 | General
Novo Nordisk A/S (NYSE:NVO) presented new analyses from its phase 3 OASIS 4 clinical trial at the European Congress on Obesity 2026 in Istanbul, highlighting the long-term weight loss potential and functional benefits of its oral obesity treatment, Wegovy pill. The...
Recent Comments